Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
Sponsor: University Hospital, Tours
Summary
Hypothesis of this study is the existence of a relation between parameters measured by FibroScan® FS 502 according to our non invasive method and liver steatosis condition. This proof of concept validation is made up of two steps: * Step 1: feasibility study of the method on 10 healthy volunteers * Step 2: diagnosis study on 50 healthy volunteers (25 between 18-30 years-old and 25 between 40-65 years-old) and on 25 patients whom cares including an liver biopsy et whom the histological answer is clean steatosis (NAFLD). Experimental procedures consist in: * Fibroscan measure, preceded by tracking ultrasonography. * liver MRI (for substudy about MRI comparison, in step 2) * a blood test for biological assessment of liver functions
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2013-04
Completion Date
2015-11
Last Updated
2026-06-15
Healthy Volunteers
Yes
Conditions
Interventions
Fibroscan
Three series oh independent measures Measure done with Fibroscan will be preceded by tracking ultrasonography.
Blood test for biological assessment of liver function
Blood test for biological assessment of liver function
MRI
Liver MRI
Locations (1)
University Hospital of Tours
Tours, France